Liping Li, Jung Hyun Kim, Wenyan Lu, Donna M. Williams, L. Xian, Joseph Kim, O. Rogers, R. Rampal, R. Koche, L. Cope, K. Reddy, D. Matson, Joe Zhao, J. Spivak, A. Moliterno, L. Resar
{"title":"摘要2666:HMGA1:通过诱导GATA-2进行MPN进展和通过增强子重组进行细胞周期进展所需的表观遗传学开关","authors":"Liping Li, Jung Hyun Kim, Wenyan Lu, Donna M. Williams, L. Xian, Joseph Kim, O. Rogers, R. Rampal, R. Koche, L. Cope, K. Reddy, D. Matson, Joe Zhao, J. Spivak, A. Moliterno, L. Resar","doi":"10.1158/1538-7445.AM2021-2666","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":23364,"journal":{"name":"Tumor Biology","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Abstract 2666: HMGA1: An epigenetic switch required for MPN progression by inducingGATA-2and cell cycle progression through enhancer rewiring\",\"authors\":\"Liping Li, Jung Hyun Kim, Wenyan Lu, Donna M. Williams, L. Xian, Joseph Kim, O. Rogers, R. Rampal, R. Koche, L. Cope, K. Reddy, D. Matson, Joe Zhao, J. Spivak, A. Moliterno, L. Resar\",\"doi\":\"10.1158/1538-7445.AM2021-2666\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":23364,\"journal\":{\"name\":\"Tumor Biology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Tumor Biology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1158/1538-7445.AM2021-2666\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Biochemistry, Genetics and Molecular Biology\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Tumor Biology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1158/1538-7445.AM2021-2666","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Biochemistry, Genetics and Molecular Biology","Score":null,"Total":0}
期刊介绍:
Tumor Biology is a peer reviewed, international journal providing an open access forum for experimental and clinical cancer research. Tumor Biology covers all aspects of tumor markers, molecular biomarkers, tumor targeting, and mechanisms of tumor development and progression.
Specific topics of interest include, but are not limited to:
Pathway analyses,
Non-coding RNAs,
Circulating tumor cells,
Liquid biopsies,
Exosomes,
Epigenetics,
Cancer stem cells,
Tumor immunology and immunotherapy,
Tumor microenvironment,
Targeted therapies,
Therapy resistance
Cancer genetics,
Cancer risk screening.
Studies in other areas of basic, clinical and translational cancer research are also considered in order to promote connections and discoveries across different disciplines.
The journal publishes original articles, reviews, commentaries and guidelines on tumor marker use. All submissions are subject to rigorous peer review and are selected on the basis of whether the research is sound and deserves publication.
Tumor Biology is the Official Journal of the International Society of Oncology and BioMarkers (ISOBM).